Gomisin K1(CAS: 75629-20-8)

Gomisin K1 (CAS: 75629-20-8) falls under various regulatory guidelines including GHS classification for hazardous chemicals, REACH regulations for substances placed on the European market, and FDA/EPA requirements for safety and environmental standards. Compliance with these guidelines is essential for handling, storage, and transportation.

Alternatives to Gomisin K1 (CAS: 75629-20-8) in synthesis include related compounds like gomisins A and B, as well as synthetic analogs. Isomers such as gomisin K2 can also serve as effective substitutes. Common alternative reagents include various ketones and alcohols that can be used in similar reactions.

The market for Gomisin K1 (CAS: 75629-20-8) is growing due to its potential in anticancer and anti-inflammatory applications. Research trends are focused on its pharmacological properties and development of new derivatives. Price trends are influenced by increased demand, with emerging studies highlighting its medicinal potential.

Waste containing Gomisin K1 (CAS: 75629-20-8) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method, but environmental protection precautions must be taken to prevent pollution. Compliance with local and national regulations is crucial throughout the waste handling process.